Eisai Reports Strong Q1 Financials and Updates FY2026 Outlook
Eisai Co., Ltd. reported first-quarter GAAP earnings per share (EPS) of ¥64.71, with revenue reaching ¥234.3 billion—up 15.6% year-over-year. The company is progressing toward its FY2026 financial targets: it has achieved 27% of the projected annual revenue and 35% of expected operating profit as of this quarter. The results reflect strong performance across Eisai’s operations, driven by continued demand for key products such as Leqembi. The company remains on track to meet its long-term goals despite ongoing challenges in the pharmaceutical sector.
Tickers: $BIIB
Topics: Earnings Outlook Guidance Revenue Growth